At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 545 enrolled
Drug / intervention
Pitavastatindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Open-Label, Long-Term (> 1 Year) Extension Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
In Brief
A Phase 3 clinical trial evaluating Pitavastatin for Hypercholesterolemia and Dyslipidemias. Completed, enrolled 545 participants across 59 sites in 5 countries.
Detailed Summary
This is an open-label extension study of NK-104-306 (NCT00257686) for elderly patients with hypercholesterolemia or combined dyslipidemia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypercholesterolemia, Dyslipidemias
CountriesDenmark, Germany, Israel, Netherlands, United Kingdom
Collaborators--
Timeline
Phase 3CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 2006
Enrollment StartJun 2006
Primary CompletionDec 2007
TodayJul 2026
First PostedMay 29, 2006
Enrollment StartJun 1, 2006
Primary CompletionDec 1, 2007
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 20.1 years ago
Interventions
Pitavastatindrug